Login / Signup

Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: a phase III randomized clinical noninferiority trial.

Xiaoyuan HuangTing FanLi LiXuanxuan NianJiayou ZhangXuefen GaoWei ZhaoWei ChenZhaoqing ZhangZhihao YaoXixin HanJinrong ShiYing WangHaihe BianNianmin ShiXinguo LiKai DuanGuohua LiXiaoming Yang
Published in: Human vaccines & immunotherapeutics (2022)
IIV4-W was noninferior to the TIV-matched strains and was superior to the additional B strain. IIV4-W was safe in the participants and elicited high antibody titers.
Keyphrases
  • phase iii
  • open label
  • double blind
  • clinical trial
  • placebo controlled
  • phase ii
  • escherichia coli
  • study protocol
  • randomized controlled trial